Ankylosing spondylitis (AS) is a chronic, inflammatory type of arthritis that primarily affects the spine and sacroiliac joints. It is a progressive condition that causes pain and stiffness in the spine, hips, and shoulders. The pain and stiffness associated with AS can be severe and can significantly impact a person’s quality of life. Treatment for AS includes medications, physical therapy, and lifestyle modifications. Recently, new treatments have been developed that may be more effective in managing the symptoms of AS. This article provides a comprehensive guide to exploring new treatment options for ankylosing spondylitis.
Medications are the mainstay of treatment for AS. Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used to reduce inflammation and pain. These medications are available over-the-counter or by prescription. Other medications, such as disease-modifying anti-rheumatic drugs (DMARDs) or biologic response modifiers, may be prescribed to slow the progression of AS. DMARDs work by blocking the action of certain proteins that cause inflammation. Biologic response modifiers are newer medications that work by targeting specific parts of the immune system.
Physical therapy is an important part of treatment for AS. Physical therapists can teach patients exercises that can help reduce pain and improve mobility. The exercises may include stretching, strengthening, and aerobic activities. Physical therapists can also teach patients how to use assistive devices, such as canes or braces, to help manage their symptoms.
Lifestyle modifications are also important in managing the symptoms of AS. These modifications may include avoiding activities that can worsen symptoms, such as strenuous exercise or heavy lifting. It is important to maintain a healthy weight, as being overweight can worsen symptoms. It is also important to get enough rest and to practice stress-reduction techniques, such as yoga or meditation.
In recent years, new treatments for AS have been developed. One such treatment is the use of intra-articular injections. These injections are given directly into the affected joint and contain a steroid to reduce inflammation. Other treatments include the use of stem cell therapy and platelet-rich plasma (PRP) injections. Stem cell therapy involves injecting stem cells into the affected joint to promote healing. PRP injections are injections of platelets and growth factors that can help reduce inflammation and promote healing.
Ankylosing spondylitis is a chronic, inflammatory type of arthritis that can cause significant pain and stiffness. Treatment for AS includes medications, physical therapy, and lifestyle modifications. Recently, new treatments have been developed that may be more effective in managing the symptoms of AS. This article provided a comprehensive guide to exploring new treatment options for ankylosing spondylitis. With the help of a healthcare professional, patients can find the best treatment plan to help manage their symptoms.
1.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
2.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
3.
Research finds stark disparities in treatment and survival time for people with pancreatic cancer
4.
Tumor characteristics found to differ for melanomas in children, teens and young adults
5.
Relationship-building key to addressing oncologist shortages in rural care
1.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
2.
Colon cancer: Risk factors, warning signs and treatment options
3.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
4.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation